Search research articles
Contact Us
Filters
Showing results (1-10 of 49) with videos related to
Page
of 5
Sort By:
Clinical Therapeutics
|
August 24, 2010
Progress toward development of vaccines against melioidosis: A review
Mitali Sarkar-Tyson, Richard W Titball
Future Microbiology
|
June 29, 2011
Antimicrobials for bacterial bioterrorism agents
Mitali Sarkar-Tyson, Helen S Atkins
Microbes and Infection
|
May 7, 2014
The use of a three-dimensional cell culture model to investigate host-pathogen interactions of Francisella tularensis in human lung epithelial cells
Jonathan David, Natalie M Sayer, Mitali Sarkar-Tyson
Journal of the Royal Society, Interface
|
September 14, 2018
Integrated human-virus metabolic stoichiometric modelling predicts host-based antiviral targets against Chikungunya, Dengue and Zika viruses
Sean Aller, Andrew Scott, Mitali Sarkar-Tyson, et al.
Microbial Pathogenesis
|
January 28, 2014
The serine protease inhibitor Ecotin is required for full virulence of Burkholderia pseudomallei
Philip M Ireland, Laura Marshall, Isobel Norville, et al.
Virulence
|
October 22, 2022
Pathogenicity and virulence of <i>Burkholderia pseudomallei</i>
Nicole M Bzdyl, Clare L Moran, Justine Bendo, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
March 17, 2019
The Detroit 562 Pharyngeal Immortalized Cell Line Model for the Assessment of Infectivity of Pathogenic Neisseria sp
Emily A Kibble, Mitali Sarkar-Tyson, Geoffrey W Coombs, et al.
Antibiotics (Basel, Switzerland)
|
September 28, 2023
Phosphoethanolamine Transferases as Drug Discovery Targets for Therapeutic Treatment of Multi-Drug Resistant Pathogenic Gram-Negative Bacteria
Van C Thai, Keith A Stubbs, Mitali Sarkar-Tyson, et al.
Environmental Microbiology
|
January 5, 2024
N-acetyl-β-hexosaminidase activity is important for chitooligosaccharide metabolism and biofilm formation in Burkholderia pseudomallei
Clare L Moran, Aleksandra Debowski, Alice Vrielink, et al.
Current Opinion in Structural Biology
|
September 18, 2018
Enzyme targets for drug design of new anti-virulence therapeutics
Charlene M Kahler, Mitali Sarkar-Tyson, Emily A Kibble, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 49) with videos related to
Sort By:
Page
of 5
Clinical Therapeutics
|
August 24, 2010
Progress toward development of vaccines against melioidosis: A review
Mitali Sarkar-Tyson, Richard W Titball
Future Microbiology
|
June 29, 2011
Antimicrobials for bacterial bioterrorism agents
Mitali Sarkar-Tyson, Helen S Atkins
Microbes and Infection
|
May 7, 2014
The use of a three-dimensional cell culture model to investigate host-pathogen interactions of Francisella tularensis in human lung epithelial cells
Jonathan David, Natalie M Sayer, Mitali Sarkar-Tyson
Journal of the Royal Society, Interface
|
September 14, 2018
Integrated human-virus metabolic stoichiometric modelling predicts host-based antiviral targets against Chikungunya, Dengue and Zika viruses
Sean Aller, Andrew Scott, Mitali Sarkar-Tyson, et al.
Microbial Pathogenesis
|
January 28, 2014
The serine protease inhibitor Ecotin is required for full virulence of Burkholderia pseudomallei
Philip M Ireland, Laura Marshall, Isobel Norville, et al.
Virulence
|
October 22, 2022
Pathogenicity and virulence of <i>Burkholderia pseudomallei</i>
Nicole M Bzdyl, Clare L Moran, Justine Bendo, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
March 17, 2019
The Detroit 562 Pharyngeal Immortalized Cell Line Model for the Assessment of Infectivity of Pathogenic Neisseria sp
Emily A Kibble, Mitali Sarkar-Tyson, Geoffrey W Coombs, et al.
Antibiotics (Basel, Switzerland)
|
September 28, 2023
Phosphoethanolamine Transferases as Drug Discovery Targets for Therapeutic Treatment of Multi-Drug Resistant Pathogenic Gram-Negative Bacteria
Van C Thai, Keith A Stubbs, Mitali Sarkar-Tyson, et al.
Environmental Microbiology
|
January 5, 2024
N-acetyl-β-hexosaminidase activity is important for chitooligosaccharide metabolism and biofilm formation in Burkholderia pseudomallei
Clare L Moran, Aleksandra Debowski, Alice Vrielink, et al.
Current Opinion in Structural Biology
|
September 18, 2018
Enzyme targets for drug design of new anti-virulence therapeutics
Charlene M Kahler, Mitali Sarkar-Tyson, Emily A Kibble, et al.
Page
of 5